Elaine Phuah, DO, MBA, FACOI, and our team specialize in medical weight loss
Across the SURMOUNT trials, hair loss affected 5.4 percent of tirzepatide users (119 of 2,183) against 0.9 percent on placebo (22 of 2,221)
Diet & Lifestyle Consultation Post-Surgery Follow-Up Free Cab Facility 24*7 Patient Support Your doctor reviews your diabetes history, medications, weight, and overall health
March 4, 2025: GLP-1 Lawsuits Exceed 1,500 as More Plaintiffs Come Forward About Harm from Mounjaro Recent research and patient complaints revealed that Mounjaro and other GLP-1 products have caused people to suffer severe complications or die after taking this diabetes drug, which is also touted as a miracle weight loss injection